Balloon Catheter

Cath Lab

Balloon Catheter

Bard Announces First Patient Enrolled in Lutonix Below the Knee (BTK) Clinical Trial

C. R. Bard Inc. announced the enrollment of the first patient into the Lutonix Below the Knee (BTK) Clinical Trial at The Cardiac and Vascular Institute in Gainesville, Fla. The purpose of this pivotal global, multi-center randomized Investigation...

Interventional Treatment During C-Section Can Save Mother’s Life, Prevent Hysterectomy

Using tiny balloons to temporarily block blood flow to the uterus during a high-risk Caesarean-section delivery can save the life of the mother while preventing hysterectomy and preserving fertility, suggests research being presented at the 25th a...

Boston Scientific Launches Emerge PTCA Balloon Dilatation Catheter in the U.S.

September 28, 2012 — Boston Scientific Corp. announced it has received U.S. Food and Drug Administration (FDA) clearance for the Emerge percutaneous transluminal coronary angioplasty (PTCA)...

Companies Developing Drug-Eluting Balloons

Several paclitaxel drug-eluting balloons (DEBs) are currently available on the European market, and several others are in development. There are currently no DEBs available in the United States.

Lutonix Drug Coated Balloon C. R. Bard Inc. PAD Treatments Clinical Trial
Bard Announces First Patient Enrolled in Lutonix Below the...
C. R. Bard Inc. announced the enrollment of the first patient into the Lutonix Below the Knee (BTK) Clinical Trial at The Cardiac and Vascular Institute in...
Covidien Introduces RX Balloon Engineered for Below the Knee
Covidien recently introduced its RapidCross 0.014-inch Rapid Exchange Percutaneous Transluminal Angioplasty (PTA) Balloon, which offers rapid exchange (RX)...
Market Drivers for U.S. PTCA and Cutting Balloon Catheters
The total U.S. market for PTCA and cutting balloon catheters was valued at $293.5 million in 2012. The PTCA balloon segment accounted for close to 90 percent...
V8 Aortic Valvuloplasty Balloon Catheter InterValve
InterValve Receives 510(k) Clearance for V8 Aortic...
InterValve Inc. announced that it has received 510(k) clearance to market the new V8 Aortic Valvuloplasty Balloon Catheter in the United States.  
Covidien Introduces RX Balloon Engineered for Below the Knee
Covidien recently introduced its RapidCross 0.014-inch Rapid Exchange Percutaneous Transluminal Angioplasty (PTA) Balloon, which offers
V8 Aortic Valvuloplasty Can Be Used in Stand-Alone BAV, TAVR Pre-Dilation
The new V8 Aortic Valvuloplasty Balloon Catheter is designed to be used in stand-alone balloon aortic valvuloplasty (BAV), and pre-dilation...
100 mm Length AngioSculpt Scoring Balloons to Aid Treatment of Peripheral Artery Disease Below the Knee
The 100 mm length AngioSculpt PTA Scoring Balloon Catheters for the treatment of peripheral artery disease (PAD) below the knee (BTK) have...
Boston Scientific Launches Emerge PTCA Balloon Dilatation Catheter in the U.S.
Boston Scientific Corp. received U.S. Food and Drug Administration (FDA) clearance for the Emerge percutaneous transluminal coronary...
View All »

Articles

Market Drivers for U.S. PTCA and Cutting Balloon Catheters
The total U.S. market for PTCA and cutting balloon catheters was valued at $293.5 million in 2012. The PTCA balloon segment accounted for close to 90 percent...
guidewire, CTO
FDA Approves Use of Common Abbott Devices to Treat for...
Physicians have new tools for treating chronic total occlusions (CTOs) after Abbott received U.S. Food and Drug Administration (FDA) approval for guidewires...
C-section Hysterectomy Clinical trial Interventional Radiology Balloon Catheter
Interventional Treatment During C-Section Can Save Mother’s...
Using tiny balloons to temporarily block blood flow to the uterus during a high-risk Caesarean-section delivery can save the life of the mother while...
Companies Developing Drug-Eluting Balloons
Several paclitaxel drug-eluting balloons (DEBs) are currently available on the European market, and several others are in development. There are currently no...

Video Center

view all Videos »

New Trends and Technology in Electrophysiology from HRS 2013
The Heart Rhythm Society (HRS) 2013 scientific sessions covered the latest research and technology...
1 week 4 days ago
The Radial Access Adoption Report Card
Over the past decade in the United States, there has been growing interest in transradial artery...
14 weeks 5 days ago
Game-Changing Technologies to Watch in 2013
My job as editor of DAIC is to help readers keep tabs on the latest in cardiovascular technology...
19 weeks 7 hours ago
View All »
EP lab, Tom De potter, depotter, angiography dose reduction
Less is More — Radiation Exposure Reduction in the EP Lab
This webinar focuses on implementation of different strategies to reduce radiation exposure during interventional electrophysiology (EP) procedures. It offers an overview of the current state-of-the-...
Iterative Reconstruction in CT: Understanding and Implementation
Radiation exposure from multidetector CT (MDCT) has become a pressing public health concern in both lay and medical publications. Implementation of iterative reconstruction offers radiologists the...
Healthcare Reform: What’s the Immediate Impact on Cardiovascular IT?
The recent U.S. Supreme Court ruling upholding the 2010 Affordable Care Act (ACA) may have significant impact on healthcare providers and their cardiovascular departments. While the ruling will...